JPH0249775A - Heterocyclic compound having 6-membered or 7-membered ring and production thereof - Google Patents
Heterocyclic compound having 6-membered or 7-membered ring and production thereofInfo
- Publication number
- JPH0249775A JPH0249775A JP23362888A JP23362888A JPH0249775A JP H0249775 A JPH0249775 A JP H0249775A JP 23362888 A JP23362888 A JP 23362888A JP 23362888 A JP23362888 A JP 23362888A JP H0249775 A JPH0249775 A JP H0249775A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- group
- formulas
- tables
- general formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 11
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 36
- 125000003118 aryl group Chemical group 0.000 claims abstract description 16
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 15
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 13
- 125000003710 aryl alkyl group Chemical group 0.000 claims abstract description 8
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims abstract description 5
- 125000003342 alkenyl group Chemical group 0.000 claims abstract description 3
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 3
- 125000000753 cycloalkyl group Chemical group 0.000 claims abstract description 3
- 125000004043 oxo group Chemical group O=* 0.000 claims abstract description 3
- 239000000126 substance Substances 0.000 claims description 14
- 229910052739 hydrogen Inorganic materials 0.000 claims description 7
- 239000001257 hydrogen Substances 0.000 claims description 7
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 5
- 125000001424 substituent group Chemical group 0.000 claims description 4
- 239000000460 chlorine Substances 0.000 claims description 2
- 229910052801 chlorine Inorganic materials 0.000 claims description 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- -1 cyano, carbamoyl Chemical group 0.000 abstract description 13
- 239000003814 drug Substances 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 239000000463 material Substances 0.000 abstract description 2
- 229920000642 polymer Polymers 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 239000003905 agrochemical Substances 0.000 abstract 1
- 239000002304 perfume Substances 0.000 abstract 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 239000013078 crystal Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 9
- 239000000203 mixture Substances 0.000 description 9
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 8
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- 125000004149 thio group Chemical group *S* 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- LRANPJDWHYRCER-UHFFFAOYSA-N 1,2-diazepine Chemical compound N1C=CC=CC=N1 LRANPJDWHYRCER-UHFFFAOYSA-N 0.000 description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 150000002148 esters Chemical class 0.000 description 3
- 150000002431 hydrogen Chemical group 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- LULAYUGMBFYYEX-UHFFFAOYSA-N 3-chlorobenzoic acid Chemical compound OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- AIJULSRZWUXGPQ-UHFFFAOYSA-N Methylglyoxal Chemical compound CC(=O)C=O AIJULSRZWUXGPQ-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000007810 chemical reaction solvent Substances 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 150000002825 nitriles Chemical class 0.000 description 2
- JMANVNJQNLATNU-UHFFFAOYSA-N oxalonitrile Chemical compound N#CC#N JMANVNJQNLATNU-UHFFFAOYSA-N 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 125000000464 thioxo group Chemical group S=* 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- XIFVSHJDIVUZJB-UHFFFAOYSA-N 2,3-diaminoprop-2-enenitrile Chemical compound NC=C(N)C#N XIFVSHJDIVUZJB-UHFFFAOYSA-N 0.000 description 1
- CKUVSPQGYLELRG-UHFFFAOYSA-N 2-chloro-6-methylpyrazine Chemical compound CC1=CN=CC(Cl)=N1 CKUVSPQGYLELRG-UHFFFAOYSA-N 0.000 description 1
- ULQQGOGMQRGFFR-UHFFFAOYSA-N 2-chlorobenzenecarboperoxoic acid Chemical compound OOC(=O)C1=CC=CC=C1Cl ULQQGOGMQRGFFR-UHFFFAOYSA-N 0.000 description 1
- BWLBGMIXKSTLSX-UHFFFAOYSA-N 2-hydroxyisobutyric acid Chemical compound CC(C)(O)C(O)=O BWLBGMIXKSTLSX-UHFFFAOYSA-N 0.000 description 1
- UWZQTYQYHJLIRS-UHFFFAOYSA-N 2-methyl-6-(methylthio)pyrazine Chemical compound CSC1=CN=CC(C)=N1 UWZQTYQYHJLIRS-UHFFFAOYSA-N 0.000 description 1
- VAUCOCSGTRUZBW-UHFFFAOYSA-N 2-phenylsulfanylpyrazine Chemical compound C=1N=CC=NC=1SC1=CC=CC=C1 VAUCOCSGTRUZBW-UHFFFAOYSA-N 0.000 description 1
- VGUOAQYMXUDOTB-UHFFFAOYSA-N 3-(benzenesulfonyl)pyrazine-2-carbonitrile Chemical compound N=1C=CN=C(C#N)C=1S(=O)(=O)C1=CC=CC=C1 VGUOAQYMXUDOTB-UHFFFAOYSA-N 0.000 description 1
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 1
- LMNUFQBYLIVBKB-UHFFFAOYSA-N 3-methylsulfanylpyrazine-2-carbonitrile Chemical compound CSC1=NC=CN=C1C#N LMNUFQBYLIVBKB-UHFFFAOYSA-N 0.000 description 1
- XPZFFVYXGVOBMX-UHFFFAOYSA-N 3-phenylsulfanylpyrazine-2-carbonitrile Chemical compound N#CC1=NC=CN=C1SC1=CC=CC=C1 XPZFFVYXGVOBMX-UHFFFAOYSA-N 0.000 description 1
- 125000004070 6 membered heterocyclic group Chemical group 0.000 description 1
- KXUOIHWSSNTEPE-UHFFFAOYSA-N 6-methyl-1h-pyrazin-2-one Chemical compound CC1=CN=CC(O)=N1 KXUOIHWSSNTEPE-UHFFFAOYSA-N 0.000 description 1
- 150000000660 7-membered heterocyclic compounds Chemical class 0.000 description 1
- QWOJMRHUQHTCJG-UHFFFAOYSA-N CC([CH2-])=O Chemical compound CC([CH2-])=O QWOJMRHUQHTCJG-UHFFFAOYSA-N 0.000 description 1
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 238000006254 arylation reaction Methods 0.000 description 1
- SLUNEGLMXGHOLY-UHFFFAOYSA-N benzene;hexane Chemical compound CCCCCC.C1=CC=CC=C1 SLUNEGLMXGHOLY-UHFFFAOYSA-N 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000007809 chemical reaction catalyst Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 125000001309 chloro group Chemical group Cl* 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000000911 decarboxylating effect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 239000012954 diazonium Substances 0.000 description 1
- 150000001989 diazonium salts Chemical class 0.000 description 1
- 125000004177 diethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- MQRJBSHKWOFOGF-UHFFFAOYSA-L disodium;carbonate;hydrate Chemical class O.[Na+].[Na+].[O-]C([O-])=O MQRJBSHKWOFOGF-UHFFFAOYSA-L 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 238000005227 gel permeation chromatography Methods 0.000 description 1
- 150000008282 halocarbons Chemical class 0.000 description 1
- 230000026030 halogenation Effects 0.000 description 1
- 238000005658 halogenation reaction Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000012456 homogeneous solution Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 230000002988 nephrogenic effect Effects 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 239000012038 nucleophile Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 239000013076 target substance Substances 0.000 description 1
- UTLZBWAGLRNNAY-UHFFFAOYSA-J thorium(4+);dicarbonate Chemical compound [Th+4].[O-]C([O-])=O.[O-]C([O-])=O UTLZBWAGLRNNAY-UHFFFAOYSA-J 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
Landscapes
- Plural Heterocyclic Compounds (AREA)
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、6員環及び7員環の複素環化合物及びその製
造方法に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a 6- and 7-membered heterocyclic compound and a method for producing the same.
含窒素複素環にチオ基(R′S基 R′は任含の首換基
を表す)を導入するにはハロゲン置換複素環とR′SH
の反応、チオキソ基を有する複素環のアルキル化もしく
はアリール化、アゾ化合物とR’SHとのカップリング
反応が主なものである。しかし複素環のハロゲン化はそ
の制御条件が難しく、好ましくない反応が起こり、又好
ましくない反応生成物がしばしば得られる事が多く、目
的とするハロゲン置換複素環を得るのが困難な場合が多
い。さらにチオキソ体やジアゾニウム塩を合成する時に
それぞれの複素環に応した良い方法がなく、本発明のチ
オ基を有する複素環を合成する事は容易ではない。しか
もシアノ基を有する複素環を合成するのは非常に困難と
いわざるをえない。To introduce a thio group (R'S group, R' represents any substituent group) into a nitrogen-containing heterocycle, a halogen-substituted heterocycle and R'SH
The main reactions include the alkylation or arylation of a heterocycle having a thioxo group, and the coupling reaction between an azo compound and R'SH. However, in the halogenation of heterocycles, the control conditions are difficult, undesirable reactions occur, and undesirable reaction products are often obtained, and it is often difficult to obtain the desired halogen-substituted heterocycle. Furthermore, when synthesizing thioxo derivatives and diazonium salts, there is no suitable method suitable for each type of heterocycle, and it is not easy to synthesize the thio group-containing heterocycle of the present invention. Moreover, it must be said that it is extremely difficult to synthesize a heterocycle having a cyano group.
含窒素複素環化合物は農医薬、香料、ポリマーの原#1
等に使用されている利用範囲の広い化合物群である。特
にシアノ置換複素環はシアノ基を他の官能基に変換出来
るので、きわめて価値があると考えらや、る。さらにチ
オ基の導入により置換反応を行なうことによって、チオ
基を他の求核試剤と置き変えることが可能となるため、
いっそうの有用性が期待されるものである。Nitrogen-containing heterocyclic compounds are the #1 raw material for agricultural medicines, fragrances, and polymers.
It is a group of compounds that have a wide range of applications and are used in In particular, cyano-substituted heterocycles are considered to be extremely valuable because they can convert the cyano group into other functional groups. Furthermore, by introducing a thio group and performing a substitution reaction, it becomes possible to replace the thio group with another nucleophile.
It is expected that it will be even more useful.
本発明はチオ基を有するモノシアノ復素環を実用的に製
造する方法を提供するものである。The present invention provides a method for practically producing a monocyano heterocycle having a thio group.
本発明は一船式CI]
〔式中、Rはへテロ環で置換されていてもよいアルキル
基、アラルキル基、シクロアルキル基、アルケニル基又
は置換基を有してもよいアリール基を、nはO,l、2
を、R’ は水素、シアノ基、カルボニル基S又は弐
COOR3(式中、R3は水素、アルキル基、アラルキ
ル基又はアリール基を示す。)で表わされるノ、腎を、
R2はアルキルノル、置換基を有してもよいアリール基
、アルコキシカルボニル基又はオキソ基を、mは0.1
.2(mが2以上のときR2は同一であっても相異って
いてもよい。)を示し、二つのR2が一緒Gこなって環
を形成してもよい。ZはC−C又はC−C−Cを示し、
供線は各結合が二重結合をとりうることを示す。)で表
わされる化合物及びその製造方法である。[In the formula, R is an alkyl group that may be substituted with a heterocycle, an aralkyl group, a cycloalkyl group, an alkenyl group, or an aryl group that may have a substituent, is O, l, 2
, R' is hydrogen, a cyano group, a carbonyl group S or 2COOR3 (in the formula, R3 represents hydrogen, an alkyl group, an aralkyl group or an aryl group);
R2 is alkylnor, an aryl group which may have a substituent, an alkoxycarbonyl group, or an oxo group, m is 0.1
.. 2 (when m is 2 or more, R2 may be the same or different), and two R2 may be combined with G to form a ring. Z represents C-C or C-C-C,
The connecting lines indicate that each bond can be a double bond. ) and its production method.
本発明の化合物に6いて、チオ基とシアン)5を同時に
複素環に導入するためには、下記−殺伐([1で示され
る、3(1ンにR3基(Rは…■記と同し意味を示す。In order to simultaneously introduce 6, thio group and cyanogen 5 into the heterocycle in the compound of the present invention, the following method is used: and indicate the meaning.
)をもつ2.3−ジアミノアクリロニトリル(以下DA
ANと略記する。)、
N CCN H□
あるいはその有機塩(p−トルエンスルホン酸塩等)、
無機塩(塩酸塩等)を出発原料として用いる。) with 2,3-diaminoacrylonitrile (hereinafter referred to as DA
Abbreviated as AN. ), N CCN H□ or an organic salt thereof (p-toluenesulfonate, etc.),
Inorganic salts (such as hydrochloride) are used as starting materials.
(]) ピピランの製造法
(III) (IV)式中、Rは
i:I記と同し意味を示し、R’、rr5 は夫々水素
、アルキル基、アラルキル基、アリール基又はアルコキ
シカルボニル基を示す。(]) Method for producing pipyran (III) (IV) In the formula, R has the same meaning as i:I, and R' and rr5 each represent hydrogen, an alkyl group, an aralkyl group, an aryl group, or an alkoxycarbonyl group. show.
反応(6媒はエタノールのようなアルコール(1、酢酸
エチルのようなエステル類、アセトニトリルのようなニ
トリル類、トルエン等の炭化水素inが用いられるが、
それらのものの混合物でもよい。Reaction (6 solvents used are alcohols such as ethanol (1), esters such as ethyl acetate, nitriles such as acetonitrile, and hydrocarbons such as toluene,
A mixture of these may also be used.
(2)ノオキソピラジンの製造法
< v ) 〔Vl ]式中、R
は(1;I記と同し意味を示す。R6は塩素又;よイミ
ダヅール基を示す。(2) Method for producing nooxopyrazine <v) [Vl] where, R
(1; has the same meaning as in Section I. R6 represents chlorine or imidazyl group.
反応、溶媒はジオキサンのようなエーテル類、クロロポ
ルムのようなハロゲノ化炭化水素類、トルエ/ヤクロロ
ヘンゼンのような芳香族tl¥が用いられる。For the reaction, ethers such as dioxane, halogenated hydrocarbons such as chloroporm, and aromatic tl such as toluene/yachlorohenzene are used.
(3)ジアゼピンの製造法
式中、Rは11り記と回し意味を示す。R” R1+
はアルキル基、アリール基又はR’ Rθが一緒に
なってI(スを示す。(3) Method for producing diazepine In the formula, R indicates the meaning in numerals. R” R1+
represents an alkyl group, an aryl group, or R' Rθ taken together.
反応溶媒はエタノールのようなアルコールt′n、酢酸
エチルのようなエステル類、アセトニド“ノルのような
ニトリルjlT、トルエン等の炭化水素類が用いられる
が、それらのものの混合物でもよい。As the reaction solvent, alcohols such as ethanol, esters such as ethyl acetate, nitriles such as acetonide, and hydrocarbons such as toluene are used, but mixtures thereof may also be used.
触媒はシュウ酸、ρ−トルエンスルホン酸のような有機
酸、硫酸や五酸化リンのような無機酸が用いられる。The catalyst used is an organic acid such as oxalic acid or ρ-toluenesulfonic acid, or an inorganic acid such as sulfuric acid or phosphorus pentoxide.
(4)ジヒド「Jジアゼピンの製造法
式中、Rは1j11記と同じ意味を示す。R9RlGは
アルキル基又はアリール基を示す。(4) Method for producing dihydro "J diazepine In the formula, R has the same meaning as in 1j11. R9RlG represents an alkyl group or an aryl group.
反応溶媒、触媒は、(3)ジアゼピンの製造法の項で記
載された反応溶媒、触媒が用いられる。As the reaction solvent and catalyst, those described in the section (3) Method for producing diazepine are used.
本発明の化合物のスルフィドは、酸化反応により、m−
クロロ過安息香酸や過酸化水素等の有■及び無機の酸化
剤を用いて相当するスルホキシドやスルホ/を得ること
ができる。又反応を円滑に進行するために適当な触媒を
用いることができる。The sulfide of the compound of the present invention can be converted to m-
The corresponding sulfoxides and sulfonyl compounds can be obtained using organic and inorganic oxidizing agents such as chloroperbenzoic acid and hydrogen peroxide. Further, an appropriate catalyst can be used to smoothly proceed the reaction.
又シアノ基を加水分解、脱炭酸することにより、カル・
hモ・イル基、カルボキシル基を経て水素に変換するこ
とができる。In addition, by hydrolyzing and decarboxylating the cyano group, cal-
It can be converted to hydrogen via an h-mo-yl group or a carboxyl group.
反応終了後は通常の後処理を行うことにより目的物を得
ることができる。After the reaction is completed, the desired product can be obtained by carrying out usual post-treatments.
本発明の化合物の構造は、[R,NMR,Ma sS等
から決定した。The structure of the compound of the present invention was determined from [R, NMR, MasS, etc.
次に実施例を挙げ本発明化合物を更に説明する。 Next, the compounds of the present invention will be further explained with reference to Examples.
実 施 例 1
2−シアノ−56−ジフェニル−3−フェニルチオピラ
ジン(化合物番号1)
n−ヘキサンから再結晶を行い7.6g(収率70%)
の結晶を得た。m、 p、 137−138 ’CNM
R,l R,Ma s sスペクトルの結果は目的物の
構造を支持するが既知化合物への導入によりさらに確認
した。すなわち目的物とメチラートとの反応により得ら
れた生成物はJ、 lleterocyclicChe
m、、+7455(1980)に記載されている既知物
質である2−シアノ−3−メトキシ−56−ジフェニル
ピラジンと全く同じものである。Example 1 2-cyano-56-diphenyl-3-phenylthiopyrazine (compound number 1) Recrystallized from n-hexane to give 7.6 g (yield 70%)
crystals were obtained. m, p, 137-138'CNM
The R,lR,Mass spectrum results supported the structure of the target product, which was further confirmed by incorporation into known compounds. That is, the product obtained by the reaction of the target substance and methylate is J, lleterocyclicChe.
It is exactly the same as 2-cyano-3-methoxy-56-diphenylpyrazine, which is a known substance described in J. M., +7455 (1980).
(Ph:フェニル基を示す。)
2.3−ジアミノ−3−フェニルチオアクリロニトリル
(以下Ph5−DAANと略記する。) 5.7g(
0,0298モル)をエタノール100m Nにとかし
、ヘンシル6、I g (0,029モル)を加え、
室温で2時間撹拌した。析出した結晶を濾過し、ヘンゼ
ン実 施 例 2
2−シアノ−5,6−シメチルー3−フェニルチオピラ
ジン(化合物番号2)
PhS−DAANI9.I g (0,1モル)を酢
酸エチル400IIIβにとかしたC6液に無水硫酸マ
グネシウム3gを加え、撹拌しながら8.6g (0
,1モル)のジアセチルを滴下し、室温で1時間撹拌し
た。反応混合物に活性炭1gを加えfjI遇し、濾液を
減圧下溜去すると・23gの黄色結晶が残るので、ベン
ゼン−n−ヘキサン(1:1)から再結晶を行い20.
51Tの白色結晶を得た。収率85%
m、 p、 +09−110°C
実 施 例 3
2−シアノ−3−メチルチオピラジン(化合物番号3)
CIl山DAAN ・++ s O3−<矛Σ山6
g (0,02モル)と40%グリオキヂール2.9
g (0,02モル)を 100m1のエタノール中
、50〜60゛cで2時間撹1′トしたエタノールを溜
去後酢酸エチル100m l加え、不溶物を濾過しでか
ら溶液を希塩酸で洗浄し、無水硫酸マグネシウムで乾燥
した。酢酸エチルを溜去後践る残、査をn−ヘキサンが
ら再結晶を行うと1.5g (収率50%)の結晶が得
られた。(Ph: indicates a phenyl group.) 2.3-diamino-3-phenylthioacrylonitrile (hereinafter abbreviated as Ph5-DAAN) 5.7 g (
0,0298 mol) was dissolved in 100 mN ethanol, Hensyl 6, Ig (0,029 mol) was added,
Stirred at room temperature for 2 hours. The precipitated crystals were filtered and added to Hensen's Example 2 2-cyano-5,6-dimethyl-3-phenylthiopyrazine (Compound No. 2) PhS-DAANI9. 3 g of anhydrous magnesium sulfate was added to a C6 solution prepared by dissolving I g (0.1 mol) in 400 IIIβ ethyl acetate, and while stirring, 8.6 g (0
, 1 mol) of diacetyl was added dropwise, and the mixture was stirred at room temperature for 1 hour. 1 g of activated carbon was added to the reaction mixture, and the filtrate was distilled off under reduced pressure. 23 g of yellow crystals remained, so they were recrystallized from benzene-n-hexane (1:1).
White crystals of 51T were obtained. Yield 85% m, p, +09-110°C Example 3 2-cyano-3-methylthiopyrazine (compound number 3) CIl mountain DAAN ・++ s O3-< Σ mountain 6
g (0.02 mol) and 40% glyochidyl 2.9
g (0.02 mol) was stirred in 100 ml of ethanol at 50-60°C for 2 hours. After distilling off the ethanol, 100 ml of ethyl acetate was added, the insoluble matter was filtered, and the solution was washed with dilute hydrochloric acid. , dried over anhydrous magnesium sulfate. After distilling off the ethyl acetate, the residue was recrystallized from n-hexane to obtain 1.5 g (yield: 50%) of crystals.
m、 p、 81.5〜82.5°C
実
施 例 4
シアノ−5−メチル
メチルチオピラ
ジン(化合物番号4)
N M RlI R1Massスペクトルの結果は目的
物の構造を支持づる。m, p, 81.5-82.5°C Example 4 Cyano-5-methylmethylthiopyrazine (Compound No. 4) N M RlI R1Mass spectrum results support the structure of the target product.
目的物の脱ソアノ化物はJ OC29415(+964
)に記載のある2−ヒドロキシ−6−メチルピラジンを
塩素化し2−クロロ−6−メチルピラジンとしメチルメ
ルカプチド (C1l、5Na) との反応で得られ
る2−メチルチオ−6−メチルピラジンと全く同しもの
であった。The desoanated product of the target product is JOC29415 (+964
) is exactly the same as 2-methylthio-6-methylpyrazine, which is obtained by chlorinating 2-hydroxy-6-methylpyrazine to produce 2-chloro-6-methylpyrazine and reacting it with methylmercaptide (C1l, 5Na). It was a servant.
をアセトニトリル200m 12 に懸濁させ、トリエ
チルアミン3.1g (0,03モル)を加えた。均一
?w液になってから40%ピルビックアルデヒド5,4
g(0,03モル)を加え、2時間室温で撹拌した。ア
セトニトリルを溜去して残る残漬にベンゼンを加え、不
7容物を濾過し、飽和食塩水で洗浄し無水硫酸マグ名シ
ウムで乾燥した。ベンゼンを溜去すると5gのネ■生成
吻が残るので、ソリカゲル力うムクロマトグラフィー(
流出溶媒ベンゼン)で精製した。3.6g (収率7
3%)の黄色斜状結晶が得られた。m、 p、83〜8
4.5°C
実 施 例 5
5 G−ジメチル−3−フェニルチオピラジン2−カル
ボキサミド(化合物番号31)2−シアノ−5,6−シ
メチルー3=フエニルチオピラジンlogを濃硫酸60
m l中に加え1日撹(!シた。反応混合物を500m
βの氷水中乙こあけ析出した結晶を1.l#過し、水で
充分洗浄し乾す・”Jした。was suspended in 200 m 12 of acetonitrile, and 3.1 g (0.03 mol) of triethylamine was added. Uniform? 40% pyruvic aldehyde 5,4 after turning into w liquid
g (0.03 mol) and stirred at room temperature for 2 hours. Benzene was added to the residue left after acetonitrile was distilled off, and the residue was filtered, washed with saturated saline, and dried over anhydrous magnesium sulfate. When the benzene is distilled off, 5 g of the nephrogenic residue remains, so it is subjected to solica gel chromatography (
The effluent solvent was benzene). 3.6g (yield 7
3%) of yellow oblique crystals were obtained. m, p, 83-8
4.5°C Example 5 5 G-dimethyl-3-phenylthiopyrazine 2-carboxamide (compound number 31) 2-cyano-5,6-dimethyl-3=phenylthiopyrazine log was dissolved in concentrated sulfuric acid 60
ml and stirred for 1 day.The reaction mixture was
1. Pour the precipitated crystals of β into ice water. Wash thoroughly with water and dry.
10g(収率93%)の目的物を得た。10 g (yield 93%) of the target product was obtained.
m、 p、 208−209.5°C(酢酸エチルから
再結晶)。m, p, 208-209.5 °C (recrystallized from ethyl acetate).
実 施 例 6
56−ツメチルー、゛3−フェニルチオピラジン2−カ
ルボン酸(化合物番号33)
ェニルチオピラジンー2=カルボキサミド5gを[5%
塩酸80m2に)」口え加熱還lんを3時間行った。Example 6 56-Thmethyl-,3-phenylthiopyrazine-2-carboxylic acid (Compound No. 33) 5g of phenylthiopyrazine-2=carboxamide was added to [5%
The mixture was heated and refluxed in 80 m2 of hydrochloric acid for 3 hours.
反応混合物を酢酸エチルで抽出した後、減圧下で溶媒を
溜去して残る残渣をカセイソーダでアルカリ性にすると
結晶が析出するから濾別し、この結晶を0=塩酸で処理
すると一旦とけてすくに白色結晶が析出した。水で充分
洗浄して乾燥した。1.2g(収率24%)の目的物を
得た。After extracting the reaction mixture with ethyl acetate, the solvent is distilled off under reduced pressure, and the remaining residue is made alkaline with caustic soda. Crystals precipitate, so they are filtered out. When these crystals are treated with 0=hydrochloric acid, they dissolve once and are easily drained. White crystals precipitated. It was thoroughly washed with water and dried. 1.2 g (yield 24%) of the target product was obtained.
m、 p、 12=L5−126’C。m, p, 12=L5-126'C.
実 施 例 7
5.6−ジメチル−3〜フエニルチオピラジン2−カル
71εン酸エチル(化合物番号34)実施例6で得られ
た5、6−ジメチル−3−フェニルチオ−2−ピラジン
カルボン酸1gを濃硫酸を触媒にして50m 1.エタ
ノール中で5時間加熱還7・ンした。アルコールを溜去
すると結晶が残るので・\/ゼンーn−ヘキサンから再
結晶を行い1g実施例5で得られた5、6−ノメチルー
3−フ(90%)の目的物を得た。Example 7 5,6-dimethyl-3-phenylthiopyrazine 2-car71eethyl ester (Compound No. 34) 5,6-dimethyl-3-phenylthio-2-pyrazinecarboxylic acid obtained in Example 6 50ml using 1g of concentrated sulfuric acid as a catalyst 1. The mixture was heated to reflux in ethanol for 5 hours. When the alcohol was distilled off, crystals remained, so recrystallization was performed from n-hexane to obtain 1 g of the desired product, 5,6-nomethyl-3-f (90%) obtained in Example 5.
m、 p、 79−80°C
実 施 例 8
2−シアノ−3−フェニルスルホニルピラジン(化合物
番号22)
実 施 例 9
23−ツメチル
5−フェニルチオピラジン
(化合物層5じ−37)
10gの2−シアノ−3−フエニルチオピラジンヲ20
0mff1のクロロホルムに溶解し、10°C以下に冷
やしたところへm−クロル過安息香酸17gを少喰ずつ
加え、10°C以下に保った。加え終わったらそのまま
室温にもどし、3時間撹1′ドシた。析出した結晶(m
−クロロ安息香酸)を濾過し、a液を炭酸すトリウム水
で3度洗浄した後、飽和食塩水で洗浄した。有殿層を分
離した後、無水硫酸マグ7シウムで乾燥し、減圧4縮し
た。エタノール、または、クロロホルム−〇−ヘキサン
で再結晶したf&9.1gの白色結晶を得た。(収率7
9%)m、 p、 120.5−121.5°C5,6
−シメチルー3−フェニルチオピラジン−2−カルホキ
4ノミド 1.3gを15%塩酸50m l中CZ ?
、 Qさせ、3時間加熱還流した。その間不拘−から均
一な溶液に変化した。反応混合液を分液ロートに移し、
飽和食塩水を入れると白濁するから、酢酸エチル100
m Eを入れて抽出を行った。m, p, 79-80°C Example 8 2-cyano-3-phenylsulfonylpyrazine (Compound No. 22) Example 9 23-Tmethyl5-phenylthiopyrazine (Compound Layer 5-37) 10g of 2 -Cyano-3-phenylthiopyrazine 20
The mixture was dissolved in 0 mff1 of chloroform and cooled to below 10°C, and then 17 g of m-chloroperbenzoic acid was added in small portions and the temperature was kept below 10°C. After the addition was complete, the mixture was returned to room temperature and stirred for 3 hours. The precipitated crystals (m
-chlorobenzoic acid) was filtered, and the solution a was washed three times with thorium carbonate water and then with saturated saline. After separating the precipitate layer, it was dried over anhydrous magnesium sulfate and concentrated under reduced pressure. Recrystallized from ethanol or chloroform-〇-hexane, 9.1 g of white crystals were obtained. (yield 7
9%) m, p, 120.5-121.5°C5,6
-Simethyl-3-phenylthiopyrazine-2-calphoky4nomide 1.3 g in 50 ml of 15% hydrochloric acid CZ?
, Q, and heated under reflux for 3 hours. During that time, the solution changed from uncontained to a homogeneous solution. Transfer the reaction mixture to a separatory funnel;
If you add saturated saline, it will become cloudy, so add 100% ethyl acetate.
Extraction was performed by adding mE.
0.4gの目的物を得た。 収率40%n o :1.
6192その他の生成物は5.6−ノツチルー3−フェ
ニルチオピラジン−2−カルボン酸であった。0.4 g of the target product was obtained. Yield 40% no: 1.
6192 Other product was 5,6-notty-3-phenylthiopyrazine-2-carboxylic acid.
実 施 例 10
5−ノアノー6−フェニルチオ−23−ビラジンノカル
ボン酸ンエチル(化合物番号35)0.96 gのPh
5−DAANを20m lのエタノールに溶解した中に
室温で、ジオキソ酒石酸ジエチル1.01gを滴下した
。室温で1時間撹拌した後加熱還流を2時間行なった。Example 10 Ph of 0.96 g of ethyl 5-noano-6-phenylthio-23-virazinenocarboxylate (Compound No. 35)
1.01 g of diethyl dioxotartrate was added dropwise to a solution of 5-DAAN in 20 ml of ethanol at room temperature. After stirring at room temperature for 1 hour, the mixture was heated under reflux for 2 hours.
エタノールを減圧留去し、残渣を水にあけ酢酸エチルを
抽出、無水硫酸マグネシウムで乾燥後、酢酸エチルと減
圧留去した。カラム績製(クロロホルム)により1.3
4 gの黄色結晶を得た。(収率75%)
m、 p、 83〜84°C
実 施 例 11
5−シアノ−2,3−ジオキソー6−フエニルチオ−1
,2,3,4−テトラヒドロピラジン(化合物番号36
)
シュウ酸クロリド1.3gを20m lのジオキサンに
7容かしたl容、・夜に12〜15°CでPh5−DA
AN 1.9 gのジオキサン?8iff12On/
!を滴下した。滴下後室温で30分撹拌し、さらに50
°Cで90分加熱した (発生する HCIを除去)
TLCT:DAANの消失を確認した後反応溶液を
ロータリーエバポレーク−で減圧下ジオキサンを留去し
た。杓1.79gの粗生成物が得られた。この粗生成物
を飽和炭酸ソーダ水に溶かし不l容物を濾過した後、4
Hc+にて中和し1gの生成物を得た。Ethanol was distilled off under reduced pressure, and the residue was poured into water to extract ethyl acetate. After drying over anhydrous magnesium sulfate, ethyl acetate was distilled off under reduced pressure. 1.3 by column preparation (chloroform)
4 g of yellow crystals were obtained. (Yield 75%) m, p, 83-84°C Example 11 5-cyano-2,3-dioxo-6-phenylthio-1
, 2,3,4-tetrahydropyrazine (compound number 36
) 1.3 g of oxalyl chloride in 7 volumes of 20 ml of dioxane, Ph5-DA at 12-15°C at night.
AN 1.9 g of dioxane? 8iff12On/
! was dripped. After dropping, stir at room temperature for 30 minutes, and then stir for 50 minutes.
Heated at °C for 90 minutes (removes generated HCI)
TLCT: After confirming the disappearance of DAAN, dioxane was distilled off from the reaction solution under reduced pressure using a rotary evaporator. A ladle of 1.79 g of crude product was obtained. After dissolving this crude product in saturated sodium carbonate water and filtering off the insoluble matter,
Neutralization with Hc+ gave 1 g of product.
収率41% m、 p、 250°C以上。Yield 41% m, p, 250°C or higher.
実 施 例 12
2−シアノ−57−シメチルー3−フェニルチオ−1’
、4,6H−ジアゼピン(化合物番号40)ρhs、D
AAN1.91 gをヘンぎン20m f!に懸濁し
、アセデルアセトン1.1gとンユウ酸0.03gを加
え、加熱コ流下、共沸脱水により水を留去しながら3時
間反応した。反応終了後、反応液を冷却し、不(古物を
除)fした後、溶媒を留去した。残渣をシリカゲル力ラ
ムクロマトグラフィークこよθF+’t ’14して「
]的1i 1.2 g <: f5 タ。If!1LI
7.1%m、 p、 lll−111,5’C実
施 例 13
2− ノアノー5.6−シヒドロー7−メチル2〕−フ
ェニル−3−フェニルチオ−1,4,4F+ジアゼピン
(化合物番号43)
PhS−DAAN 1.91 gのエタノール?容液
にヘンデルアセトノ1.46gを加え、次いで濃硫酸0
.05gを加え室温にて3時間反応した。反応終了後反
応液を水にあけて、酢酸エチルで抽出し、酢酸エチル層
を水洗後無水硫酸マグ不ノウムで乾燥した後、溶媒を留
去した。残渣をシリカゲルカラムクロマトグラフィーに
より情調して目的物2.7gを得た。Example 12 2-cyano-57-dimethyl-3-phenylthio-1'
, 4,6H-diazepine (compound number 40) ρhs, D
AAN1.91g 20m f! 1.1 g of acedelacetone and 0.03 g of phosphoric acid were added, and the mixture was reacted for 3 hours while water was distilled off by azeotropic dehydration under heating. After the reaction was completed, the reaction solution was cooled and filtered (old materials were removed), and then the solvent was distilled off. The residue was subjected to silica gel force column chromatography θF+'t'14.
] Target 1i 1.2 g <: f5 ta. If! 1LI
7.1% m, p, lll-111,5'C real
Example 13 2-Noano5,6-sihydro7-methyl2]-phenyl-3-phenylthio-1,4,4F+Diazepine (Compound No. 43) PhS-DAAN 1.91 g of ethanol? Add 1.46 g of Handel acetonate to the solution, then add 0.0 g of concentrated sulfuric acid.
.. 05 g was added and reacted at room temperature for 3 hours. After the reaction was completed, the reaction solution was poured into water and extracted with ethyl acetate. The ethyl acetate layer was washed with water, dried over anhydrous magnesium sulfate, and then the solvent was distilled off. The residue was analyzed by silica gel column chromatography to obtain 2.7 g of the desired product.
収・ト85% no : 1.658(1−1−記実施
例の化合物もなめて 本発明化合物の代表例を第1表、
第2表Qこ示す。Yield: 85% No.: 1.658 (including the compounds of Examples 1-1-) Representative examples of the compounds of the present invention are shown in Table 1.
Table 2 shows Q.
第
表
〔発明の効果〕
本発明の化合物は、農医薬、香料、染料、」ミリマー等
の原料ないし中間体として任用であり、DA A Nを
出発原料として工業的に有利に製造できる。Table 1 [Effects of the Invention] The compounds of the present invention can be used as raw materials or intermediates for agricultural medicines, fragrances, dyes, millimers, etc., and can be advantageously produced industrially using DAAN as a starting material.
出
代
理
人
人
(430)日本曹達株式会社
(7125) 横 山 吉 美果1頁の続き
■Int、 C1,’
識別記号
庁内整理番号
″[相]発
[相]発
明
明
者
者
波
田
多
崎
野
裕
こ4己
7日
美
治
神奈川県小田原市高田字柳町345 日本曹達株式会
社小田原研究所内
岡山県倉敷市児島塩生字新浜2767−12 日本曹
達株式会社水島工場内Representative (430) Nippon Soda Co., Ltd. (7125) Yoshi Yokoyama Mika Continued from page 1 ■Int, C1,' Identification code Internal reference number "[Ai] From [Ai] Inventor Hiroshi Hata Tasakino 4/7 days Miji 345 Yanagimachi, Takada, Odawara City, Kanagawa Prefecture Odawara Research Institute, Nippon Soda Co., Ltd. 2767-12 Niihama, Kojima Shio, Kurashiki City, Okayama Prefecture Inside the Mizushima Factory of Nippon Soda Co., Ltd.
Claims (5)
基、アラルキル基、シクロアルキル基、アルケニル基又
は置換基を有してもよいアリール基を、nは0、1、2
を、R^1は水素、シアノ基、カルバモイル基又は式C
OOR^3(式中、R^3は水素、アルキル基、アラル
キル基又はアリール基を示す。)で表わされる基を、R
^2はアルキル基、置換基を有してもよいアリール基、
アルコキシカルボニル基又はオキソ基を、mは0、1、
2(mが2以上のときR^2は同一であっても相異って
いてもよい。)を示し、二つのR^2が一緒になって環
を形成してもよい。ZはC−C又はC−C−Cを示し、
点線は各結合が二重結合をとりうることを示す。〕で表
わされる化合物。(1) General formula [I] ▲ Numerical formulas, chemical formulas, tables, etc.▼ [I] [In the formula, R is an alkyl group, an aralkyl group, a cycloalkyl group, an alkenyl group, which may be substituted with a heterocycle, or a substituted an aryl group which may have a group, n is 0, 1, 2
, R^1 is hydrogen, cyano group, carbamoyl group or formula C
A group represented by OOR^3 (wherein R^3 represents hydrogen, an alkyl group, an aralkyl group, or an aryl group), R
^2 is an alkyl group, an aryl group which may have a substituent,
an alkoxycarbonyl group or an oxo group, m is 0, 1,
2 (when m is 2 or more, R^2 may be the same or different), and two R^2 may be combined to form a ring. Z represents C-C or C-C-C,
The dotted line indicates that each bond can be a double bond. ] A compound represented by
合物と一般式〔III〕▲数式、化学式、表等があります
▼(式中、R^4、R^5は夫々水素、アルキル基、ア
ラルキル基、アリール基、アルコキシカルボニル基又は
R^4、R^5が一緒になって環を示す。)で表わされ
る化合物とを反応させることを特徴とする一般式〔IV〕
▲数式、化学式、表等があります▼〔IV〕 (式中、R、R^4及びR^5は前記と同じ意味を示す
。)で表わされる化合物の製造方法。(2) General formula [II] ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [II] (In the formula, R has the same meaning as above.) Compounds represented by the general formula [III] ▲ Numerical formulas, chemical formulas, There are tables, etc. ▼ (In the formula, R^4 and R^5 are each hydrogen, an alkyl group, an aralkyl group, an aryl group, an alkoxycarbonyl group, or R^4 and R^5 together represent a ring.) General formula [IV] characterized by reacting with a compound represented by
▲There are mathematical formulas, chemical formulas, tables, etc.▼ [IV] (In the formula, R, R^4 and R^5 have the same meanings as above.) A method for producing a compound represented by the formula.
合物と一般式〔V〕▲数式、化学式、表等があります▼
(式中、 R^6は塩素又はイミダゾール基を示す。)で表わされ
る化合物とを反応させることを特徴と する一般式〔VI〕 ▲数式、化学式、表等があります▼〔VI〕 (式中、Rは前記と同じ意味を示す。)で表わされる化
合物の製造方法。(3) General formula [II] ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [II] (In the formula, R has the same meaning as above.) Compounds represented by the general formula [V] ▲ Numerical formulas, chemical formulas, There are tables etc.▼
(In the formula, R^6 represents chlorine or imidazole group.) General formula [VI] ▲There are mathematical formulas, chemical formulas, tables, etc.▼[VI] (In the formula , R has the same meaning as above).
合物と一般式〔VII〕▲数式、化学式、表等があります
▼ (式中、R^7、R^8はアルキル基、アリール基又は
R^7、R^8が一緒になって環を示す。)で表わされ
る化合物とを反応させることを特徴とする一般式〔VII
I〕 ▲数式、化学式、表等があります▼〔VIII〕 (式中、R、R^7及びR^8は前記と同じ意味を示す
。)で表わされる化合物の製造方法。(4) General formula [II] ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [II] (In the formula, R has the same meaning as above.) Compounds represented by the general formula [VII] ▲ Numerical formulas, chemical formulas, There are tables etc. ▼ (In the formula, R^7 and R^8 are an alkyl group, an aryl group, or R^7 and R^8 together represent a ring.) Featured general formula [VII
I] ▲There are mathematical formulas, chemical formulas, tables, etc.▼[VIII] (In the formula, R, R^7 and R^8 have the same meanings as above.) A method for producing a compound represented by the formula.
合物と一般式〔IX〕 ▲数式、化学式、表等があります▼〔IX〕 (式中、R^9、R^1^0はアルキル基又はアリール
基を示す。)で表わされる化合物とを反応させることを
特徴とする一般式〔X〕 ▲数式、化学式、表等があります▼〔X〕 (式中、R、R^9及びR^1^0は前記と同じ意味を
示す。)で表わされる化合物の製造方法。(5) General formula [II] ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [II] (In the formula, R has the same meaning as above.) Compounds represented by the general formula [IX] ▲ Numerical formulas, chemical formulas, There are tables etc. ▼ [IX] General formula [X] characterized by reacting with a compound represented by (wherein R^9 and R^1^0 represent an alkyl group or an aryl group) ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ [X] (In the formula, R, R^9 and R^1^0 have the same meanings as above.) A method for producing a compound represented by.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP23362888A JPH0249775A (en) | 1988-05-19 | 1988-09-20 | Heterocyclic compound having 6-membered or 7-membered ring and production thereof |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP63-120729 | 1988-05-19 | ||
| JP12072988 | 1988-05-19 | ||
| JP23362888A JPH0249775A (en) | 1988-05-19 | 1988-09-20 | Heterocyclic compound having 6-membered or 7-membered ring and production thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0249775A true JPH0249775A (en) | 1990-02-20 |
Family
ID=26458256
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP23362888A Pending JPH0249775A (en) | 1988-05-19 | 1988-09-20 | Heterocyclic compound having 6-membered or 7-membered ring and production thereof |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0249775A (en) |
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999019314A1 (en) * | 1997-10-10 | 1999-04-22 | Abbott Laboratories | Process for preparing substituted pyrazine compounds |
| US8115000B2 (en) | 2006-06-22 | 2012-02-14 | Mallinckrodt Llc | Pyrazine derivatives and uses thereof in renal monitoring |
| US8664392B2 (en) | 2004-12-23 | 2014-03-04 | Medibeacon, LLC | Pyrazine derivatives for bioconjugation |
| US8778309B2 (en) | 2004-12-23 | 2014-07-15 | Medibeacon Llc | Fluorescent pyrazine derivatives and methods of using the same in assessing renal function |
| JP2021176870A (en) * | 2016-07-12 | 2021-11-11 | レヴォリューション・メディスンズ,インコーポレイテッド | 2,5-Disubstituted 3-methylpyrazine and 2,5,6-trisubstituted 3-methylpyrazine as allosteric SHP2 inhibitors |
| WO2022015624A1 (en) * | 2020-07-16 | 2022-01-20 | Schrödinger, Inc. | Substituted dihydropyrazinediones as modulators of the nmda receptor |
| US11364300B2 (en) | 2018-05-01 | 2022-06-21 | Revolution Medicines, Inc. | C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors |
| US11596633B2 (en) | 2017-09-07 | 2023-03-07 | Revolution Medicines, Inc. | SHP2 inhibitor compositions and methods for treating cancer |
| US11673896B2 (en) | 2017-01-23 | 2023-06-13 | Revolution Medicines, Inc. | Pyridine compounds as allosteric SHP2 inhibitors |
| US11673901B2 (en) | 2017-12-15 | 2023-06-13 | Revolution Medicines, Inc. | Polycyclic compounds as allosteric SHP2 inhibitors |
| US11685749B2 (en) | 2018-05-01 | 2023-06-27 | Revolution Medicines, Inc. | C26-linked rapamycin analogs as mTOR inhibitors |
| US11702411B2 (en) | 2017-10-12 | 2023-07-18 | Revolution Medicines, Inc. | Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors |
| US11739093B2 (en) | 2017-01-23 | 2023-08-29 | Revolution Medicines, Inc. | Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors |
| US12121522B2 (en) | 2022-05-25 | 2024-10-22 | Revolution Medicines, Inc. | Methods of treating cancer with an mTOR inhibitor |
-
1988
- 1988-09-20 JP JP23362888A patent/JPH0249775A/en active Pending
Cited By (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999019314A1 (en) * | 1997-10-10 | 1999-04-22 | Abbott Laboratories | Process for preparing substituted pyrazine compounds |
| USRE47413E1 (en) | 2004-12-23 | 2019-06-04 | Medibeacon, Inc. | Pyrazine derivatives and uses thereof in renal monitoring |
| US8778309B2 (en) | 2004-12-23 | 2014-07-15 | Medibeacon Llc | Fluorescent pyrazine derivatives and methods of using the same in assessing renal function |
| US9114160B2 (en) | 2004-12-23 | 2015-08-25 | Medibeacon, LLC | Pyrazine derivatives and uses thereof in renal monitoring |
| US9376399B2 (en) | 2004-12-23 | 2016-06-28 | Medibeacon Llc | Fluorescent pyrazine derivatives and methods of using the same in assessing renal function |
| US9480687B2 (en) | 2004-12-23 | 2016-11-01 | Medibeacon, Inc. | Pyrazine derivatives and uses thereof in renal monitoring |
| US8664392B2 (en) | 2004-12-23 | 2014-03-04 | Medibeacon, LLC | Pyrazine derivatives for bioconjugation |
| USRE47255E1 (en) | 2004-12-23 | 2019-02-26 | Medibeacon, Inc. | Pyrazine derivatives and uses thereof in renal monitoring |
| US10617687B2 (en) | 2004-12-23 | 2020-04-14 | Medibeacon Inc. | Fluorescent pyrazine derivatives and methods of using the same in assessing renal function |
| US8115000B2 (en) | 2006-06-22 | 2012-02-14 | Mallinckrodt Llc | Pyrazine derivatives and uses thereof in renal monitoring |
| JP2021176870A (en) * | 2016-07-12 | 2021-11-11 | レヴォリューション・メディスンズ,インコーポレイテッド | 2,5-Disubstituted 3-methylpyrazine and 2,5,6-trisubstituted 3-methylpyrazine as allosteric SHP2 inhibitors |
| US12565476B2 (en) | 2016-07-12 | 2026-03-03 | Revolution Medicines, Inc. | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors |
| US11661401B2 (en) | 2016-07-12 | 2023-05-30 | Revolution Medicines, Inc. | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors |
| US12365688B2 (en) | 2017-01-23 | 2025-07-22 | Revolution Medicines, Inc. | Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors |
| US11673896B2 (en) | 2017-01-23 | 2023-06-13 | Revolution Medicines, Inc. | Pyridine compounds as allosteric SHP2 inhibitors |
| US11739093B2 (en) | 2017-01-23 | 2023-08-29 | Revolution Medicines, Inc. | Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors |
| US11596633B2 (en) | 2017-09-07 | 2023-03-07 | Revolution Medicines, Inc. | SHP2 inhibitor compositions and methods for treating cancer |
| US11702411B2 (en) | 2017-10-12 | 2023-07-18 | Revolution Medicines, Inc. | Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors |
| US11673901B2 (en) | 2017-12-15 | 2023-06-13 | Revolution Medicines, Inc. | Polycyclic compounds as allosteric SHP2 inhibitors |
| US11685749B2 (en) | 2018-05-01 | 2023-06-27 | Revolution Medicines, Inc. | C26-linked rapamycin analogs as mTOR inhibitors |
| US12048749B2 (en) | 2018-05-01 | 2024-07-30 | Revolution Medicines, Inc. | C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors |
| US12187746B2 (en) | 2018-05-01 | 2025-01-07 | Revolution Medicines, Inc. | C26-linked rapamycin analogs as mTOR inhibitors |
| US11364300B2 (en) | 2018-05-01 | 2022-06-21 | Revolution Medicines, Inc. | C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors |
| US12544448B2 (en) | 2018-05-01 | 2026-02-10 | Revolution Medicines, Inc. | C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors |
| WO2022015624A1 (en) * | 2020-07-16 | 2022-01-20 | Schrödinger, Inc. | Substituted dihydropyrazinediones as modulators of the nmda receptor |
| US12121522B2 (en) | 2022-05-25 | 2024-10-22 | Revolution Medicines, Inc. | Methods of treating cancer with an mTOR inhibitor |
| US12539305B2 (en) | 2022-05-25 | 2026-02-03 | Revolution Medicines, Inc. | Methods of treating cancer with an mTOR inhibitor |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0249775A (en) | Heterocyclic compound having 6-membered or 7-membered ring and production thereof | |
| US3822275A (en) | Process for producing 3-indolyl aliphatic acid compounds | |
| HU207841B (en) | Process for producing biphenyl-carbonitrils | |
| JPH0272136A (en) | Naphthalene derivative, production and synthetic intermediate thereof | |
| Funt et al. | An Azirine Strategy for the Synthesis of Alkyl 4-Amino-5-(trifluoromethyl)-1H-pyrrole-2-carboxylates | |
| Sun et al. | One-pot and divergent synthesis of furo [3, 2-c] quinolines and quinazolin-4 (3H)-ones via sequential isocyanide-based three-component/Staudinger/aza-Wittig reaction | |
| SU485597A3 (en) | The method of obtaining derivatives-triazole / 1,5-a / -pyrimidines | |
| FR2595695A1 (en) | N - ((((2-HYDROXYHYL) PHENYL) (PHENYL) METHYLENE) AMINO-2) ETHYL) ACETAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE | |
| US4797496A (en) | Process for the preparation of pyrrolidone derivatives | |
| KR100749843B1 (en) | 2,4-quinazoline deivatives having activity to t-type calcium channel and preparation method thereof | |
| ZA200502694B (en) | Aplha-phenyl acetanilide derivatives having an acat inhibiting activity and therapeutic application thereof. | |
| US3201406A (en) | Pyridylcoumarins | |
| SU448644A3 (en) | The method of obtaining isoindoline derivatives | |
| RU2026293C1 (en) | Method of synthesis of imidazole derivative | |
| US4022766A (en) | Pharmacologically active pyrrolodiazepines | |
| CN100358875C (en) | Fluorine-containing 1H-1,2,3-triazole compounds, preparation method and use thereof | |
| López-Mendoza et al. | α-Xanthylmethyl ketones from α-Diazo ketones | |
| CN108218804A (en) | A kind of 4- alkylthio groups -3- isoxazolidinones derivative and its synthetic method | |
| CN112500419A (en) | Epoxy fused 2-methylene pyrrolidine compound and preparation method thereof | |
| JPH0283373A (en) | Five-membered heterocyclic compound and production thereof | |
| CN102276601B (en) | Preparation method of indolizine derivative | |
| SU417945A3 (en) | METHOD OF OBTAINING QUINAZOLINON-2 DERIVATIVES | |
| US3798212A (en) | Resolution of benzodiazepine derivatives | |
| Pathak et al. | Indolizines in focus: Synthetic approaches, biological profiles, and SAR perspectives, a review | |
| Zhang et al. | Synthesis of [(3 S, 5 R)-3-Hydroxy-5-methylpiperidin-1-yl](2-methylpyridin-3-yl) methanone |